Core D: Pilot Project Core
核心 D:试点项目核心
基本信息
- 批准号:8977737
- 负责人:
- 金额:$ 18.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-15 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdvertisingAlcoholic Liver DiseasesAlcoholsAmerican Society of HematologyAnimal ModelAreaBiological AssayBiological MarkersCell modelCellsClinicClinicalClinical InvestigatorCollaborationsCommunitiesComplexDevelopmentDisease ProgressionDisease susceptibilityDoctor of PhilosophyElementsEnvironmentEthanolFacultyFingerprintFunctional disorderFundingFutureGoalsIndividualInjuryKidney DiseasesMagnetic ResonanceMedicineMolecular TargetMonitorOhioPathogenesisPediatric HospitalsPilot ProjectsPopulationResearchResearch PersonnelSystemTNFRSF5 geneTestingTherapeutic InterventionTissuesUniversitiesalcohol researchbasebiomarker developmentclinical investigationcollegecommunity buildingexosomeflasksinnovationmembernovelnovel strategiesnovel therapeuticsoxidationprogramsresponsesecretory IgMtargeted treatment
项目摘要
ABSTRACT
The overall goal of the Northeast Ohio Alcohol Center (NOAC) is to identify specific molecular targets
responsible for ethanol-induced tissue damage, as well as to understand the complex adaptive and
maladaptive responses of cells and systems to that damage. This information will enable us to 1) target
therapeutic interventions to slow and/or reverse the progression of alcohol-induced tissue injury and 2) develop
specific assays that can assess the efficacy of novel therapeutic strategies in relevant clinical populations. The
NOAC brings together an outstanding team of interdisciplinary investigators including geneticists, cell
biologists, oxidation biochemists, biomarker experts, synthetic chemists and clinical translational investigators.
A critical element to leveraging the expertise of our team of investigators is to provide support for pilot projects.
Pilot projects bring innovative and promising new approaches to the alcohol field and facilitate collaborations
between team members and outside investigators to build onto their existing individual research programs.
Pilot projects are supported by our Animal and Cell Models Core and Clinical Core, facilitating rapid progress
for investigators new to the area of alcohol research. Importantly, the supportive intellectual environment with
broad expertise in biomedical and clinical investigations will allow for the continued development of novel and
innovative pilot projects. Therefore, support for pilot projects will likely have a large impact on the progress of
research on mechanisms and treatments for ethanol-induced tissue injury. The Specific Aims of the Pilot
Projects Core are to 1) Advertise the availability of Pilot Projects and invite pilot projects from faculty at
Cleveland Clinic, Case Western Reserve University, Northeast Ohio College of Medicine and National
Children’s Hospital, organize their review and ranking, 2) Provide support for junior investigators in
implementing their proposals and 3)Monitor progress of Pilot Projects on a yearly basis. Implementation of the
Pilot Projects Core will allow for funding of novel and innovative hypotheses with a rapid turnaround from
conceptualization to actualization, facilitate collaborations between basic and clinical investigators and provide
seed money to test exciting new approaches to understanding pathophysiology of ethanol-induced tissue
injury, as well as development of biomarkers for disease progression and susceptibility. Importantly, the Pilot
Projects Core will also extend the numbers of participating investigators in the NOAC and continue to build a
community able and willing to conduct cutting edge basic and clinical alcohol-related research.
抽象的
东北俄亥俄酒精中心(NOAC)的总体目标是确定特定的分子靶标
负责乙醇引起的组织损伤,并了解复杂的自适应和
细胞和系统对该损伤的适应不良反应。此信息将使我们能够到1)
治疗性干预措施以减慢和/或逆转酒精诱导的组织损伤的进展,2)
可以评估相关临床人群中新型治疗策略效率的特定评估。这
NOAC汇集了一个杰出的跨学科研究人员团队,包括遗传学家,细胞
生物学家,氧化生物化学家,生物标志物专家,合成化学家和临床转化研究者。
利用我们调查人员团队的专业知识的关键要素是为试点项目提供支持。
飞行员项目为酒精领域带来了创新和承诺的新方法,并促进合作
在团队成员和外部调查人员之间,以建立他们现有的个人研究计划。
试点项目得到我们的动物和细胞模型核心和临床核心的支持,支持快速进步
适用于酒精研究领域的调查人员。重要的是,由
生物医学和临床研究方面的广泛专业知识将允许持续发展新颖和
创新的飞行员项目。因此,对飞行员项目的支持可能会对
研究乙醇诱导的组织损伤的机制和治疗方法。飞行员的具体目的
项目核心是1)宣传试点项目的可用性,并邀请教职员工的试点项目
克利夫兰诊所,凯斯西部储备大学,东北俄亥俄州医学院和国家
儿童医院,组织他们的评论和排名,2)为初级调查人员提供支持
执行其建议和3)每年监控试点项目的进度。实施
飞行员项目核心将允许资助新颖和创新的假设,并以迅速的转变。
实现概念化,促进基本研究人员和临床研究者之间的合作
种子资金测试令人兴奋的新方法,以了解乙醇诱导的组织的病理生理学
损伤,以及用于疾病进展和易感性的生物标志物的发展。重要的是,飞行员
项目核心还将扩大NOAC参与调查人员的数量,并继续建造一个
社区能够并愿意进行尖端基本和临床酒精相关的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas M McIntyre其他文献
Thomas M McIntyre的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas M McIntyre', 18)}}的其他基金
Hypertension augmented COVID-19 through renin-induced internalization of platelet-ACE2 / SARS-Cov-2 complexes
高血压通过肾素诱导血小板-ACE2/SARS-Cov-2复合物内化增强了COVID-19
- 批准号:
10490385 - 财政年份:2021
- 资助金额:
$ 18.78万 - 项目类别:
Hypertension augmented COVID-19 through renin-induced internalization of platelet-ACE2 / SARS-Cov-2 complexes
高血压通过肾素诱导血小板-ACE2/SARS-Cov-2复合物内化增强了COVID-19
- 批准号:
10275251 - 财政年份:2021
- 资助金额:
$ 18.78万 - 项目类别:
Dynamic regulation of thrombosis by the platelet proteome
血小板蛋白质组对血栓形成的动态调节
- 批准号:
9336334 - 财政年份:2016
- 资助金额:
$ 18.78万 - 项目类别:
Systemic Oxidized Phospholipids in Mitochondrial Dysfunction of Alcoholic Injury
酒精损伤线粒体功能障碍中的全身氧化磷脂
- 批准号:
7671505 - 财政年份:2008
- 资助金额:
$ 18.78万 - 项目类别:
Systemic Oxidized Phospholipids in Mitochondrial Dysfunction of Alcoholic Injury
酒精损伤线粒体功能障碍中的全身氧化磷脂
- 批准号:
7522644 - 财政年份:2008
- 资助金额:
$ 18.78万 - 项目类别:
Systemic Oxidized Phospholipids in Mitochondrial Dysfunction of Alcoholic Injury
酒精损伤线粒体功能障碍中的全身氧化磷脂
- 批准号:
8318216 - 财政年份:2008
- 资助金额:
$ 18.78万 - 项目类别:
Systemic Oxidized Phospholipids in Mitochondrial Dysfunction of Alcoholic Injury
酒精损伤线粒体功能障碍中的全身氧化磷脂
- 批准号:
8135614 - 财政年份:2008
- 资助金额:
$ 18.78万 - 项目类别:
相似国自然基金
从AMPK调控线粒体裂变和融合研究金钗石斛总生物碱抗非酒精性脂肪肝病的分子机制
- 批准号:82360808
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
果糖通过m6A识别蛋白IGF2BP3促进非酒精性脂肪性肝病的作用和机制研究
- 批准号:82300961
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
植物性饮食及肠木质素与非酒精性脂肪性肝病人群肝纤维化发生风险的前瞻性研究
- 批准号:82373673
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于Keap1-Nrf2信号通路介导的抗氧化失衡探讨红芪多糖对非酒精性脂肪肝病铁死亡的干预效应及作用机制研究
- 批准号:82360914
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
大蒜素通过调控FGFR4-AMPK-Caspase 6信号通路对非酒精性脂肪肝病的改善作用及机制研究
- 批准号:82304128
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
- 批准号:
10354185 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Role of Lysosome Damage in ALD Pathogenesis
溶酶体损伤在 ALD 发病机制中的作用
- 批准号:
10668006 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Multicellular Organotypic Mouse Model of Alcoholic Liver Disease
酒精性肝病的多细胞器官型小鼠模型
- 批准号:
10667672 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Circadian and mitochondrial dysfunction in alcohol-related liver disease
酒精相关性肝病中的昼夜节律和线粒体功能障碍
- 批准号:
10667861 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别:
Aspartate beta-hydroxylase and DNA damage in chronic liver diseases
慢性肝病中的天冬氨酸 β-羟化酶和 DNA 损伤
- 批准号:
10667881 - 财政年份:2023
- 资助金额:
$ 18.78万 - 项目类别: